AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Sectors:
Analyst Ranking
Bottom 5%
#4712 out of 4929 analysts
Average Return
-15.14%
Win Rate
28%7 out of 25
Risk vs Reward
Poor
Good
Gavin Clark-Gartner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-20 - 2024-12-20 | Buy |
C4 Therapeutics IncCCCC | +48.96% | $3.35 | $4.99 | 2023-05-29 - 2024-05-29 | Buy |
Mirum Pharmaceuticals IncMIRM | +37.60% | $28.91 | $39.78 | 2023-10-16 - 2024-10-16 | Buy |
Proqr Therapeutics NvPRQR | +33.74% | $1.63 | $2.18 | 2025-04-28 - 2025-07-03 | Buy |
Mirum Pharmaceuticals IncMIRM | +26.16% | $39.87 | $50.30 | 2024-08-07 - 2025-07-03 | Buy |
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Proqr Therapeutics NvPRQR | 1 | Buy | $5.00 | +129.36% | Initiates Coverage On | 2 months ago |
Abbvie IncABBV | 3 | Buy | $205.00 | +8.31% | Maintains | 2 months ago |
Mind Medicine IncMNMD | 1 | Buy | $23.00 | +220.78% | Initiates Coverage On | 5 months ago |
Cabaletta Bio IncCABA | 2 | Hold | $6.00 | +268.10% | Downgrades | 6 months ago |
Argenx SeARGX | 4 | Buy | $706.00 | +29.90% | Maintains | 7 months ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $170.00 | +832.02% | Maintains | 8 months ago |
Jasper Therapeutics IncJSPR | 2 | Buy | $65.00 | +860.12% | Maintains | 10 months ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $20.00 | +289.86% | Initiates Coverage On | a year ago |
Krystal Biotech IncKRYS | 1 | Buy | $206.00 | +43.98% | Maintains | a year ago |
Mirum Pharmaceuticals IncMIRM | 2 | Buy | $66.00 | +31.21% | Maintains | a year ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $10.00 | N/A | Maintains | 2 years ago |
Inhibrx IncINBX1 | 1 | Buy | $60.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.